Sign in
4

Changes in Ownership

CURIS INC Filed Acc 0001181431-08-058339

Options or other derivatives

  • VP, Research & Preclinical Dev acquired 51,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Qian Changgeng · VP, Research & Preclinical Dev

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2008-10-24 Grant or award : show line 1 in the form Non-qualified stock option (right to buy) +51,000 $0.79 $40,290 51,000 D
Loading xslF345X03/rrd221614.xml…